Results 131 to 140 of about 1,812,025 (211)
Clinical Physiology and Functional Imaging, Volume 46, Issue 6, November 2026.Abstract Background In patients with suspected coronary artery disease (CAD), diffusely impaired hyperaemic myocardial blood flow (MBF) may indicate a multivessel epicardial CAD but also impaired coronary microcirculation. We assessed whether relative hyperaemic MBF—that is, the ratio of the lowest to the highest regional hyperaemic MBF—predicts ...
Niklas Vartiainen +9 more
wiley +1 more source
Expert Systems, Volume 43, Issue 11, November 2026.ABSTRACT Purpose Prognostic models can benefit from integrating heterogeneous data sources. While deep learning‐based multimodal models often improve predictive performance, their limited interpretability remains a barrier to clinical adoption. Moreover, achieving robust generalization with such models typically requires large and diverse datasets ...
Lander Rodriguez‐Idiazabal +7 more
wiley +1 more source
Liver International, Volume 46, Issue 11, November 2026.ABSTRACT Background & Aims The management of comorbidities has become increasingly relevant in unresectable hepatocellular carcinoma (uHCC) as immunotherapy prolongs survival. Atezolizumab plus bevacizumab (AB) is a standard first‐line option, but bevacizumab carries a risk of cardiovascular toxicities.
Bernardo Stefanini +55 more
wiley +1 more source
The use of vasodilators in the management of angina
, 2020 Vasodilators are used as first line agents to relief symptoms of angina in clinical setting. First line vasodilating agents used in the management of angina include calcium channel blockers and nitrates.
Gemana, Tersee
core
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases
Arthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci +25 more
wiley +1 more source
Clinical Cardiology, Volume 49, Issue 10, October 2026.Routine screening for silent myocardial ischemia in asymptomatic adults with diabetes detected occult coronary disease but did not reduce major cardiovascular events or mortality. Current evidence supports intensive cardiovascular risk‐factor management and selective cardiac testing when results are expected to change clinical management.
Vanessa del Carmen Romero Martínez +4 more
wiley +1 more source
Food Science &Nutrition, Volume 14, Issue 10, October 2026.This graphical abstract illustrates the complete translational pipeline of Terminalia arjuna in modern phytomedicine and functional food development. It is rich in key bioactive compounds like arjunolic acid, arjungenin, flavonoids, and tannins which serve as the foundation for the plant's versatile medicinal uses and offers broad therapeutic benefits ...
Ishani Banerjee +5 more
wiley +1 more source
Prediction of Risk of Cardiovascular Events in Patients With Stable Angina Using Artificial Intelligence: A Systematic Review. [PDF]
Cardiol ResKumar S +5 more
europepmc +1 more source
Physiotherapy Research International, Volume 31, Issue 4, October 2026.ABSTRACT Background and Purpose Prolonged weaning—characterized by failure in three consecutive spontaneous breathing trials (SBTs) and requiring over 7 days of mechanical ventilation post‐initial SBT—presents a critical clinical challenge often exacerbated by intensive care unit‐acquired weakness (ICU‐AW) and impaired airway clearance.
Tsung‐Hsien Wang +2 more
wiley +1 more source